Cytosorbents (CTSO) Net Cash Flow Growth (5y) (2015 - 2026)

Cytosorbents (CTSO) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.39 Bn 174.10 Bn 6.27 Bn
2 Stryker 128.38 Bn 125.50 Bn 3.81 Bn
3 Medtronic 107.68 Bn 98.46 Bn 6.41 Bn
4 Boston Scientific 67.98 Bn 66.53 Bn 3.61 Bn
5 Edwards Lifesciences 47.81 Bn 44.13 Bn 1.29 Bn
6 GE HealthCare Technologies 28.53 Bn 26.25 Bn 1.98 Bn
7 Dexcom 28.35 Bn 27.24 Bn 750.30 Mn
8 Smith & Nephew 26.78 Bn 26.20 Bn -
9 Koninklijke Philips 25.34 Bn 22.21 Bn 2.07 Bn
10 Cytosorbents 23.46 Mn 18.66 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.92%
Dec 31, 2025 30.67%
Sep 30, 2025 -15.41%
Jun 30, 2025 -16.97%
Mar 31, 2025 -25.19%
Dec 31, 2024 9.35%
Sep 30, 2024 -56.64%
Jun 30, 2024 28.29%
Mar 31, 2024 -15.35%
Dec 31, 2023 33.36%
Sep 30, 2023 -69.54%
Jun 30, 2023 -27.60%
Mar 31, 2023 -23.08%
Dec 31, 2022 -17.97%
Sep 30, 2022 -48.46%
Jun 30, 2022 -24.33%
Mar 31, 2022 -34.95%
Dec 31, 2021 -45.16%
Sep 30, 2021 -14.63%
Jun 30, 2021 -20.86%